Definium Therapeutics Inc. Common Shares vs WisdomTree Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.97 (market cap $4.59B), while WisdomTree Inc. Common Stock trades at $22.83 (market cap $3.44B). The key difference: Definium Therapeutics Inc. Common Shares is the larger of the two by market cap, and WisdomTree Inc. Common Stock pays a 0.53% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and WisdomTree Inc. Common Stock for 0 Days on average.
| DFTX | WT | |
|---|---|---|
Market Cap | $4.59B | $3.44B |
Volume | 2,103,937 | 2,480,128 |
Sector | Health | Financials |
52-Week High | $48.45 | $25.04 |
52-Week Low | $10.68 | $10.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $4.18B |
Dividend Yield | — | 0.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →WisdomTree provides exchange-traded products, model portfolios, and digital-asset-related products and services. Its digital offerings include tokenized funds, an institutional platform, and a blockchain-native wallet.
Read more on WT →